rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2000-8-3
|
pubmed:abstractText |
Marathon runners have an increased risk of developing joint disease. During and after a 42-km run, elevation of multiple cytokines occurs in the blood, reflecting inflammatory processes. We compared this cytokine response with serum levels of cartilage oligomeric matrix protein (COMP) and melanoma inhibitory activity (MIA), two markers for joint metabolism and/or damage.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Matrix Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/MIA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1063-4584
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
222-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10806050-Adult,
pubmed-meshheading:10806050-Arthritis, Rheumatoid,
pubmed-meshheading:10806050-C-Reactive Protein,
pubmed-meshheading:10806050-Case-Control Studies,
pubmed-meshheading:10806050-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:10806050-Extracellular Matrix Proteins,
pubmed-meshheading:10806050-Humans,
pubmed-meshheading:10806050-Interleukin-1,
pubmed-meshheading:10806050-Interleukin-6,
pubmed-meshheading:10806050-Knee Injuries,
pubmed-meshheading:10806050-Neoplasm Proteins,
pubmed-meshheading:10806050-Osteoarthritis,
pubmed-meshheading:10806050-Receptors, Interleukin-1,
pubmed-meshheading:10806050-Receptors, Interleukin-6,
pubmed-meshheading:10806050-Running,
pubmed-meshheading:10806050-Time Factors,
pubmed-meshheading:10806050-Tumor Necrosis Factor-alpha
|
pubmed:year |
2000
|
pubmed:articleTitle |
Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
|
pubmed:affiliation |
Center for Experimental Rheumatology, University Hospital, Zürich, Switzerland. michel-neidhart@ruz.usz.ch
|
pubmed:publicationType |
Journal Article,
Comparative Study
|